In a recently published simulation study, Mitra and Reiter 1 compared two approaches to implementing propensity score (PS) methods following multiple imputation. Particular emphasis was on PS matching following multiple imputation. In simulation studies, they evaluated two possible approaches, i.e. the so-called Within and Across approaches. In both approaches, PSs are estimated in each of m imputed datasets. In the Within approach, PS matching is performed within each imputed dataset. The resulting m effect estimates are then pooled by averaging. In the Across approach, for each subject the m estimated PSs are averaged first, after which PS matching is performed once, based on each subject's average PS. Apparent from the results was the trend that although both approaches were biased, the Within method was generally more biased than the Across approach, particularly when there was missing confounder data.
by a factor of 10 ( Table 1 , 1(c)) it becomes apparent that the Within approach is superior to the Across provided the outcome variable is included in the imputation model. Mitra and Reiter also assessed multiple imputation followed by regression adjustment (i.e. including the confounders as covariates in a linear regression model). In this situation, we observed the same trend across the different imputation models ( Table 1 , scenarios 2(a) and 2(b)). Again, upon inclusion of the outcome variable in the imputation model, the Within approach yields unbiased estimates, while the Across approach does not.
A third method of controlling for confounding that was studied by Mitra and Reiter was inverse probability weighting. In scenario 3(a), we estimated the true effect using inverse probability of treatment weighting (IPTW) where, following Mitra and Reiter, 1 the weight for any subject equalled 1 if a subject was treated, and PS/(1-PS) if untreated. The treatment effect is then estimated by the difference between the sum of the weighted outcomes in the treatment group and the sum of the weighted outcomes in the control group, divided by the original sample size n. In scenario 3(b), we used the traditional weights discussed by, e.g. Lunceford and Davidian 3 and Robins et al. 4 ; i.e. 1/PS if a subject was treated, and 1/(1-PS) otherwise. Note that these are equivalent to those of scenario 3(a) multiplied by PS, meaning that the average of weighted outcomes based on the weights used by Mitra and Reiter is necessarily closer to zero (since PS <1), than if the traditional weights were used. Again, we observed that with the outcome variable included in the imputation model, the Within method is superior to the Across ( 2 (a, b) , treatment effects were estimated using linear regression, regressing the outcome on treatment, the PS, and both covariates. In 2(a), the outcome was left out of the imputation model, whereas in 2(b) it was included. In scenario 3, effect estimates were based on IPTW, following Mitra and Reiter 1 (a, c, e), or using the traditional weights (see text) (b, d, f). In scenarios 3(a) and (b), the outcome variable was not included in the imputation model, whereas in scenarios 3(c), (d), (e) and (f), the outcome was included in the imputation model. In all scenarios, the true effect of treatment on the outcome was zero, except for scenarios 3(e) and (f), in which it was 10. effect ¼ 10) simulations suggest that the traditional weights are to be preferred -i.e. unless the interest lies in estimating the average effect on the treated, 5 in which case the denominator of the effect estimator should match the effective size of the groups in the pseudopopulation. In medical research, confounding and missing data are common problems that often occur simultaneously. When multiple imputation is to be followed by PS matching, researchers could apply the Across and the Within approaches that were proposed by Mitra and Reiter. Provided the correct imputation model is applied and there are no other sources of bias (e.g. model misspecification), the Within approach appears to be superior to the Across approach in terms of bias reduction.
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